Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-023886
Filing Date
2011-03-10
Accepted
2011-03-10 06:45:35
Documents
9
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 IDERA PHARMACEUTICALS, INC. b84116e10vk.htm 10-K 1156799
2 EX-10.14 b84116exv10w14.htm EX-10.14 4017
3 EX-10.41 b84116exv10w41.htm EX-10.41 5526
4 EX-23.1 b84116exv23w1.htm EX-23.1 1809
5 EX-31.1 b84116exv31w1.htm EX-31.1 8498
6 EX-31.2 b84116exv31w2.htm EX-31.2 8520
7 EX-32.1 b84116exv32w1.htm EX-32.1 3036
8 EX-32.2 b84116exv32w2.htm EX-32.2 3057
9 GRAPHIC b84116b8411601.gif GRAPHIC 8090
  Complete submission text file 0000950123-11-023886.txt   1203639
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31918 | Film No.: 11676685
SIC: 2836 Biological Products, (No Diagnostic Substances)